Bruce Gil

Disney said its streaming platforms turned a profit for the second quarter in a row, helping power a Q4 earnings beat and sending the stock up 8%

Disney has until 2026 to find a replacement for its longtime and still current chief executive

The troubled genetic testing company said its sales are tanking, a day after it cut almost half its workforce

Costco voluntarily recalled some of its butter products because they were missing a "contains milk" label

Disney stock is up more than 13% so far this year, outperforming rivals such as Warner Bros. Discovery and Paramount Global

More people are pausing streaming subscriptions instead of quitting, according to new data

About 34% of subscriptions to streaming platforms between September 2023 and August 2024 came from users who were rejoining a service they had left

New data shows that the U.S. may have reached peak obesity in 2020

Tesla CEO Elon Musk's close alliance with Trump could give the EV maker a significant advantage under the new administration

The monthly subscription fee for a standard, ad-free Netflix plan has risen 94% over the last 13 years

Plus, the FDA wants to ban a common ingredient in cold and allergy medications and Ozempic seems to be a cure for everything

This proposal is based on concerns over the ingredient’s effectiveness and not its safety

Warner Bros. Discovery's streaming platform added more subscribers in the third-quarter of 2024 than Netflix

Sales of the pharma giant's weight loss drug skyrocketed 79% year-over-year

Novo Nordisk revealed more about CagriSema, its potential successor to the weight loss drug Ozempic

Sales of the pharma giant's weight loss drug skyrocketed 79% year-over-year

Numerous studies suggest that Ozempic and other GLP-1 medications may help with a range of conditions such as kidney failure, sleep apnea, Alzheimer's, and more

Zealand Pharma said its new weight loss drug doesn't come with GLP-1s number one side effect

The telehealth company will start offering a generic version of liraglutide in 2025 as some brand-name drugs remain in shortage

Novo Nordisk and Ascendis Pharma have partnered to develop a long-acting, monthly GLP-1 drug

Viking Therapeutics is racing against Ozempic maker Novo Nordisk to bring an oral weight loss drug to market

Plus, knockoff weight loss drugs are having a moment — but Eli Lilly isn’t worried

The cable company joins Warner Bros Discovery in weighing a sale of it cable channels. Comcast’s cable networks include USA and Bravo

Canvassers hired by a firm linked to Musk's PAC reportedly faced poor working conditions